Swiss All Share Index

Swiss All Share Index handeln
17.549,42 PKT +225,72 PKT +1,30 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
21.11.12 Novartis reduce Vontobel Research
21.11.12 Swiss Prime Site buy Sarasin Research
21.11.12 Swiss Prime Site hold Vontobel Research
21.11.12 DKSH hold Vontobel Research
20.11.12 Novartis outperform Exane-BNP Paribas SA
20.11.12 UBS neutral Exane-BNP Paribas SA
20.11.12 UBS outperform Exane-BNP Paribas SA
20.11.12 Holcim buy Société Générale Group S.A. (SG)
20.11.12 Novartis buy Sarasin Research
20.11.12 UBS neutral Sarasin Research
20.11.12 UBS hold Vontobel Research
20.11.12 UBS halten Norddeutsche Landesbank (Nord/LB)
19.11.12 UBS halten Norddeutsche Landesbank (Nord/LB)
19.11.12 UBS buy Sarasin Research
19.11.12 Clariant neutral HSBC
19.11.12 Zurich Insurance halten Independent Research GmbH
19.11.12 Avolta (ex Dufry) outperform Exane-BNP Paribas SA
16.11.12 Zurich Insurance neutral HSBC
16.11.12 Givaudan outperform Exane-BNP Paribas SA
16.11.12 Novartis outperform Exane-BNP Paribas SA
16.11.12 Avolta (ex Dufry) underperform Cheuvreux SA
16.11.12 Clariant neutral Exane-BNP Paribas SA
16.11.12 Zurich Insurance neutral J.P. Morgan Cazenove
16.11.12 Zurich Insurance neutral Exane-BNP Paribas SA
16.11.12 Zurich Insurance buy Nomura
16.11.12 Zurich Insurance buy Société Générale Group S.A. (SG)
16.11.12 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
16.11.12 Avolta (ex Dufry) neutral Sarasin Research
16.11.12 Zurich Insurance hold Vontobel Research
16.11.12 EMS-CHEMIE reduce Vontobel Research
16.11.12 Avolta (ex Dufry) buy Vontobel Research
15.11.12 Swiss Re kaufen Hamburger Sparkasse AG (Haspa)
15.11.12 Novartis buy UBS AG
15.11.12 Logitech equal-weight Morgan Stanley
15.11.12 Zurich Insurance neutral Sarasin Research
15.11.12 Zurich Insurance hold Vontobel Research
15.11.12 ABB (Asea Brown Boveri) buy Vontobel Research
15.11.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
14.11.12 Sonova neutral UBS AG
14.11.12 Sonova overweight J.P. Morgan Cazenove